Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice
Binghua Xue(Academy of Military Medical Sciences), Haifeng Duan(Beijing Radiation Center), Tingting Yu(Nanjing Medical University), Tao Na(National Institutes for Food and Drug Control), Jing Xie(Academy of Military Medical Sciences), Shufang Meng(National Institutes for Food and Drug Control), Xinhua Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Wang(University of Science and Technology of China), Xiuxiao Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lingjia Qian(Academy of Military Medical Sciences), Qiuhe Ji(Xijing Hospital)
Cited by 26
Related Papers
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238
A cohort study of diabetic patients and diabetic foot ulceration patients in China
|Wound Repair and Regeneration|2015|181
Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR‐185/TGF‐β1
|Journal of Cellular Physiology|2018|172